Tuesday - June 18, 2019
Case Report: Adjunctive Use of Epidiolex Eliminates Seizures in Patient With Refractory Epilepticus
January 10, 2019
LOS ANGELES, California, Jan. 10 -- The National Organization for the Reform of Marijuana Laws issued the following news release:

The adjunctive administration of the proprietary, plant-derived CBD extract Epidiolex is associated with the complete remission of seizures in a 12-year old patient with super-refractory status epilepticus (SRSE), according to a case report published in the journal Epilepsy & Behavior Case Reports.

Investigators at the David Geffen School . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products